ARK Genomic Revolution ETF
ARKG
93 hedge funds and large institutions have $142M invested in ARK Genomic Revolution ETF in 2019 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 33 increasing their positions, 15 reducing their positions, and 11 closing their positions.
120% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 15
118% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 11
38% more capital invested
Capital invested by funds: $103M → $142M (+$39.3M)
16% more funds holding
Funds holding: 80 → 93 (+13)
3.25% more ownership
Funds ownership: 25.46% → 28.71% (+3.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$8.66M |
| 2 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
+$5.31M |
| 3 |
Morgan Stanley
New York
|
+$4.95M |
| 4 |
CFA
Carroll Financial Associates
Charlotte,
North Carolina
|
+$3.05M |
| 5 |
UAM
UAS Asset Management
New York
|
+$2.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$3.44M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.07M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.24M |
| 4 |
MIAN
Mariner Independent Advisor Network
Overland Park,
Kansas
|
-$1.17M |
| 5 |
LFA
Legend Financial Advisors
Pittsburgh,
Pennsylvania
|
-$1.09M |
ARKG Hedge Fund Activity: Q4 2019 in Review
93 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q4 2019, worth a combined $142M — up 38% from $103M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new ARKG positions and 11 closed out — a net gain of 13 holders — while 33 added to existing stakes and 15 trimmed.
The largest buyer was Wells Fargo, adding an estimated $8.66M. The largest seller was Raymond James & Associates, cutting an estimated $3.44M.
- 93 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q4 2019, up from 80 in Q3 2019.
- Funds reported $142M of ARK Genomic Revolution ETF stock for Q4 2019, up 38% quarter-over-quarter.
- 24 funds opened new ARK Genomic Revolution ETF positions in Q4 2019 and 11 closed out, a net change of +13 holders.
- The largest ARK Genomic Revolution ETF buyer in Q4 2019 was Wells Fargo, an estimated $8.66M added.
- The largest ARK Genomic Revolution ETF seller in Q4 2019 was Raymond James & Associates, an estimated $3.44M sold.
Based on aggregated 13F filings for Q4 2019.